Skip to main content
SpringerLink
Log in

Investigation of the Anti-Inflammatory Effects of Safranal on High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

In the present study, it was aimed to investigate the effects of safranal, one of the components of saffron plant, on the inflammation in the rats in which experimental type 2 diabetes and obesity were formed. Type 2 diabetes is a disease characterized by insulin resistance and β-cell dysfunction. Therefore, in the present study, high-fat diet (HFD) and streptozotocin were used for being able to create experimental type 2 diabetes. In the first 6 weeks of the study, experimental groups were formed in five groups, after the stage of creating insulin resistance. The study groups were designed as control, HFD, HFD-Saf, DYB, and DYB-Saf groups. Safranal treatment was applied to the treatment groups for a period of 4 weeks. Throughout the study period (10 weeks), the weight gains and plasma glucose levels of the rats were determined each week and bi-weekly, respectively. At the end of the study, interferon gamma (IFN-γ), interleukin (IL)-1β, IL-6, tumor necrosis factor alpha (TNF-α), TAS and TOS levels in the pancreas and plasma were measured. In addition, the insulin and leptin levels in the plasma were determined. It was ascertained that, compared to the diabetic group, safranal decreased the inflammation both in the plasma and pancreas tissue, by reducing the TNF-α and IL-1β levels in particular. In addition, safranal was also found to decrease the oxidative stress increased due to type 2 diabetes in the plasma and pancreas tissue. It was concluded that safranal might be helpful in terms of reduction of diabetic complications, by means of its effects on both oxidative stress and inflammation, and that further studies should be carried out for this purpose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

REFERENCES

  1. IDF (International Diabetes Fedaration). 2014. IDF Diabetes atlas, Sixth edition, 12.

  2. Ulukaya, E. 2007. (Translation editor) Lippincott’s illustrated reviews: biochemistry, 3rd ed. Turkey: Nobel Tıp Kitabevleri.

    Google Scholar 

  3. Baxter, M. 2008. Treatmant of type 2 diabetes: a structured management plan. Advances in Therapy 25(2): 106–114.

    Article  PubMed  Google Scholar 

  4. Negbi, M., B. Dagan, A. Dror, and D. Basker. 1989. Growth, flowering, vegetative reproduction and dormancy in the saffron crocus (Crocus sativus L.). Israel Journal of Botany 38: 95–113.

    Google Scholar 

  5. Lozano, P., D. Delgado, D. Gómez, M. Rubio, and J.L. Iborra. 2000. A non-destructive method to determine the safranal content of saffron (Crocus sativus L.) by supercritical carbon dioxide extraction combined with high-performance liquid chromatography and gas chromatography. Journal of Biochemical and Biophysical Methods 43(1–3): 367–378.

    Article  CAS  PubMed  Google Scholar 

  6. Cossignani, L., E. Urbani, M.S. Simonetti, A. Maurizi, C. Chiesi, and F. Blasi. 2014. Characterisation of secondary metabolites in saffron from central Italy (Cascia, Umbria). Food Chemistry 15(143): 446–451.

    Article  Google Scholar 

  7. Kainbakht, S., and R. Hajiaghaee. 2011. Anti-hyperglycemic effects of saffron and its active constituents, crosin and safranal, in alloxan-induced diabetic rats. Journal of Medicinal Plant 10(39): 82–89.

    Google Scholar 

  8. Assimopoulou, A.N., Z. Sinakos, and V.P. Papageorgiou. 2005. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytotherapy Research 19: 997–1000.

    Article  CAS  PubMed  Google Scholar 

  9. Samarghandian, S., R. Afshari, A. Sadati. 2014. Evaluation of lung and bronchoalveolar lavage fluid oxidative stress indices for assessing the preventing effects of safranal on respiratory distress in diabetic rats. The Scientific World Journal, Article ID 251378, 6 pages http://dx.doi.org/10.1155/251378.

  10. Mehdizadeh, R., M.R. Parizadeh, A.R. Khooei, S. Mehri, and H. Hosseinzadeh. 2013. Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in Wistar rats. Iranıan Journal of Basıc Medical Sciences 16(1): 56–63.

    PubMed Central  PubMed  Google Scholar 

  11. Escribano, J., G.L. Alonso, M. Coca-Prados, and J.A. Fernandez. 1996. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Letters 100: 23–30.

    Article  CAS  PubMed  Google Scholar 

  12. Imenshahidi, M., H. Hosseinzadeh, and Y. Javadpour. 2010. Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytotherapy Research 24(7): 990–994.

    CAS  PubMed  Google Scholar 

  13. Hazman, O. 2011. Investigation of the effect of oral antidiabetic agent sitagliptin on oxidant-antioxidant balance in rats with type 2 diabetes mellitus. Turkey: Depertmant of Biochemistry, PhD Thesis, Institue of Healt Sciences, Afyon Kocatepe Universty.

    Google Scholar 

  14. Zhang, M., M.Y. Lv, J. Lı, Z.G. Xu, L. Chen. 2008. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Experimental Diabetes Research, Article ID 704045, 1–9.

  15. Erel, Ö. 2004. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 37(2): 112–119.

    Article  CAS  PubMed  Google Scholar 

  16. Erel, Ö. 2005. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 38(12): 1103–1111.

    Article  CAS  PubMed  Google Scholar 

  17. Gutierrez, D.A., M.J. Puglisi, and A.H. Hasty. 2009. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Current Diabetes Reports 9(1): 26–32.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Garcia, C., B. Feve, P. Ferré, S. Halimi, H. Baizri, L. Bordier, G. Guiu, O. Dupuy, B. Bauduceau, and H. Mayaudon. 2010. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes & Metabolism 36(5): 327–338.

    Article  CAS  Google Scholar 

  19. Fronczyk, A., P. Molęda, K. Safranow, W. Piechota, and L. Majkowska. 2014. Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control. Inflammation 37(2): 349–357.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Kim, Y.J., and T. Park. 2008. Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet. Nutrition Research 28: 414–422.

    Article  CAS  PubMed  Google Scholar 

  21. Woods, S.C., R.J. Seeley, P.A. Rushing, D. D’Alessio, and P. Tso. 2003. A controlled high-Fat diet induces an obese syndrome in rats. The Journal of Nutrition 133: 1081–1087.

    CAS  PubMed  Google Scholar 

  22. Lauterio, T.J., J.P. Bond, and E.A. Ulman. 1994. Development and characterization of a purified diet to identify obesity-susceptible and resistant rat populations. The Journal of Nutrition 124: 2172–2178.

    CAS  PubMed  Google Scholar 

  23. Reed, M.J., K. Meszaros, L.J. Entes, M.D. Claypool, J.G. Pinkett, T.M. Gadbois, and G.M. Reaven. 2000. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49(11): 1390–1394.

    Article  CAS  PubMed  Google Scholar 

  24. Hazman, Ö., and S. Çelik. 2014. Effects of oral anti-diabetic agent sitagliptin on total antioxidant and oxidant status in rats with type 2 diabetes mellitus. Journal of Applied Biological Sciences 8(1): 31–37.

    CAS  Google Scholar 

  25. Melloul, D. 2008. Role of NFkB in β-cell death. Biochemical Society Transactions 36: 334–339.

    Article  CAS  PubMed  Google Scholar 

  26. Napetschnig, J., and H. Wu. 2013. Molecular basis of NF-κB signaling. Annual Review of Biophysics 42: 443–468.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Schoonbroodt, S., and J. Piette. 2000. Oxidative stress interference with the nuclear factor-kB activation pathways. Biochemical Pharmacology 60: 1075–1083.

    Article  CAS  PubMed  Google Scholar 

  28. Bowie, A., and L.A. O’Neill. 2000. Oxidative stress and nuclear factor-kappa B activation: a reassessment of the evidence in the light of recent discoveries. Biochemical Pharmacology 59(1): 13–23.

    Article  CAS  PubMed  Google Scholar 

  29. Maeda, A., K. Kai, M. Ishii, T. Ishii, and M. Akagawa. 2014. Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice. Molecular Nutrition Food Research 58: 1177–1189.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

We declare that this study was financially supported by Scientific Research Projects Committee (project number 12.FENBIL.07), Rectorate of Afyon Kocatepe University, Afyonkarahisar, Turkey.

Author information

Authors and Affiliations

  1. Department of Chemistry, Biochemistry Division, Faculty of Science and Arts, Afyon Kocatepe University, Afyonkarahisar, Turkey

    Ömer Hazman & Serhat Ovalı

Authors
  1. Ömer Hazman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serhat Ovalı
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ömer Hazman.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hazman, Ö., Ovalı, S. Investigation of the Anti-Inflammatory Effects of Safranal on High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model. Inflammation 38, 1012–1019 (2015). https://doi.org/10.1007/s10753-014-0065-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-0065-1

KEY WORDS

Search

Navigation